AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

Affiliations

• ¹ Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK.
• ² Francis Crick Institute, London NW1 1AT, UK.
• ³ University College London, London, UK.
• ⁴ Francis Crick Institute, London NW1 1AT, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
• ⁵ Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
• ⁶ National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
• ⁷ Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
• ⁸ Francis Crick Institute, London NW1 1AT, UK. Electronic address: david.bauer@crick.ac.uk.